Retension Pharmaceuticals
A clinical-stage biopharmaceutical company advancing novel therapies for the millions of patients whose hypertension remains uncontrolled on existing treatments.
Follow our progress as RTN-001 advances through the clinic. For partnering, media and general inquiries, please get in touch.
